Drugs for metabolic diseases, vaccines, and cancer therapies feature among new product launches this year that could top $1 ...

Eli Lilly is its nearest rival ... It would allow patients with insulin-dependent diabetes to cover their basal insulin needs with one injection per week, as opposed to once or twice daily.

U-500 insulin human regular (Humulin R U-500, Eli Lilly and Company in the United ... U-500 has prandial and basal time–action profile characteristics. d Basal insulin (glargine, detemir ...

Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...

compared the efficacy and safety of a basal-bolus insulin regimen with that of sliding-scale regular insulin (SSI) in hospitalized general medical patients with type 2 diabetes. The prospective ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...

In a bid to bring down the cost of insulin, California under Gov. Gavin Newsom inked a contract to produce the drug. It's years behind the timeline he announced.

This marks the first regulatory approval of EVA Pharma's insulin drug products, following Lilly and EVA Pharma's collaboration ( ) announcement in December 2022. Under this agreement, Lilly has ...

It was noninferior to basal glargine, and one head-to-head trial showed once-weekly exenatide to be inferior to liraglutide. Albuglutide was noninferior to prandial lispro with significantly less ...

The average price per insulin unit hit a 10-year low in 2024, largely driven by federal actions and voluntary price cuts from drugmakers, according to a Jan. 15 GoodRx report. GoodRx analyzed the ...